Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,711Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Dr. Reddy's Laboratories

02 1NanoAlvand

03 3Adalvo

04 3Lotus Pharmaceutical

05 3MSN Laboratories

06 3Newbury Pharmaceuticals Ab

07 2ORIFARM GROUP AS

08 13Pfizer Inc

09 2Pinnacle Life Science

10 9STADA Arzneimittel

11 6Sandoz B2B

12 3Spirig Healthcare

13 9Teva Pharmaceutical Industries

14 3Vivanta Generics Sro

15 12Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : PRESCRIPTION

Registration Country : Canada

BOSUTINIB (BOSUTINIB DIHYDRATE)

Brand Name : REDDY-BOSUTINIB

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 2560038

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Bosutinib

Brand Name : Suliba

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : PRESCRIPTION

Registration Country : Canada

BOSUTINIB (BOSUTINIB DIHYDRATE)

Brand Name : REDDY-BOSUTINIB

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number : 2560046

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Dr Reddy Company Banner

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib Lotus

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2025-02-14

Application Number :

Regulatory Info : Authorised

Registration Country : Malta

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

bosutinib

Brand Name : Bosulif

Dosage Form : Bosutinib 100Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

bosutinib

Brand Name : Bosulif

Dosage Form : Bosutinib 500Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 500 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosulif

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 11/12/2013

Application Number : 62270

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosulif

Dosage Form : Film Coated Tablet

Dosage Strength : 500mg

Packaging :

Approval Date : 11/12/2013

Application Number : 62270

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosulif

Dosage Form : Film Coated Tablet

Dosage Strength : 400mg

Packaging :

Approval Date : 11/12/2013

Application Number : 62270

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

11

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib

Dosage Form : Tablet

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

12

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib Sandoz

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 04/06/2024

Application Number : 69145

Regulatory Info : Allowed

Registration Country : Switzerland

blank

13

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib Sandoz

Dosage Form : Film Coated Tablet

Dosage Strength : 400mg

Packaging :

Approval Date : 04/06/2024

Application Number : 69145

Regulatory Info : Allowed

Registration Country : Switzerland

blank

14

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib Sandoz

Dosage Form : Film Coated Tablet

Dosage Strength : 500mg

Packaging :

Approval Date : 04/06/2024

Application Number : 69145

Regulatory Info : Allowed

Registration Country : Switzerland

blank

15

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib Spirig HC

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 22/01/2025

Application Number : 69464

Regulatory Info : Allowed

Registration Country : Switzerland

blank

16

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib Spirig HC

Dosage Form : Film Coated Tablet

Dosage Strength : 400mg

Packaging :

Approval Date : 22/01/2025

Application Number : 69464

Regulatory Info : Allowed

Registration Country : Switzerland

blank

17

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib Spirig HC

Dosage Form : Film Coated Tablet

Dosage Strength : 500mg

Packaging :

Approval Date : 22/01/2025

Application Number : 69464

Regulatory Info : Allowed

Registration Country : Switzerland

blank

18

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib-Teva

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 28/05/2024

Application Number : 69223

Regulatory Info : Allowed

Registration Country : Switzerland

blank

19

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib-Teva

Dosage Form : Film Coated Tablet

Dosage Strength : 400mg

Packaging :

Approval Date : 28/05/2024

Application Number : 69223

Regulatory Info : Allowed

Registration Country : Switzerland

blank

20

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bosutinib

Brand Name : Bosutinib-Teva

Dosage Form : Film Coated Tablet

Dosage Strength : 500mg

Packaging :

Approval Date : 28/05/2024

Application Number : 69223

Regulatory Info : Allowed

Registration Country : Switzerland

blank